WVP
EDVA

Worth Venture Partners’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Worth Venture Partners’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-404
Closed -$16.3K – 53
2024
Q3 		$16.3K Buy
+404
New +$20.4K 0.12% 45

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Worth Venture Partners's EDVA Position: Q4 2024 in Review

Worth Venture Partners sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2024, closing a stake of 404 shares — an estimated $16.3K sold.

Worth Venture Partners first reported a position in EDVA in Q3 2024 and held it in 1 quarter. The position peaked at $16.3K in Q3 2024. 33 funds tracked by Wall St. Rank hold EDVA as of Q4 2024.

  • Worth Venture Partners reported no remaining Endovia Health Sciences, Inc. position as of Q4 2024 after selling out during the quarter.
  • Worth Venture Partners sold 404 Endovia Health Sciences, Inc. shares in Q4 2024, an estimated $16.3K.
  • Worth Venture Partners first reported a position in Endovia Health Sciences, Inc. in Q3 2024 and held it in 1 quarter.
  • Worth Venture Partners's Endovia Health Sciences, Inc. position peaked at $16.3K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2024.

Based on Worth Venture Partners's 13F filing for Q4 2024, filed 12 Feb 2025.